G'day Mer,
1. Agreed, it was confirmed by @djkencloud after last year's AGM with Bahay that there were issues with the commercial terms. Given that the desal and brines chemical facility is, potentially, a USD20 Billion project, it is probably fair to say they were insurmountable for a company of PWNs size.
2., Agreed, Enowa is developing their own ssr tech and Worley/Advisian have signed a framework agreement with them whose scope includes desal water production, brines benefication, management and storage.
From the March 2023 press release:
And:
3. I am not quite sure I would agree that (o&g) companies are slow to act in Qld. I think the industry, to date, has been acting responsibly within the confirnes of very stringent regulator environment, which has seen a number of changes over the life of these csg projects. I am not aware of any salt encapsulation facilities having been given DES approval nor any encapsulation facility in operation - so there is plenty of time to steer the right path.
.
- Forums
- ASX - By Stock
- PWN
- general chat/ thoughts
general chat/ thoughts, page-2612
-
-
- There are more pages in this discussion • 638 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PWN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.20M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $2.258K | 188.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 4455540 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2762841 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 4455540 | 0.011 |
13 | 4434212 | 0.010 |
9 | 3812394 | 0.009 |
9 | 2391000 | 0.008 |
10 | 5468548 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2762841 | 3 |
0.013 | 2912087 | 5 |
0.014 | 307441 | 3 |
0.015 | 2075892 | 6 |
0.016 | 2758482 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
PWN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online